Gyrodyne (GYRO)
Market Price (3/4/2026): $9.31 | Market Cap: $1.3 MilSector: Real Estate | Industry: Real Estate Services
Gyrodyne (GYRO)
Market Price (3/4/2026): $9.31Market Cap: $1.3 MilSector: Real EstateIndustry: Real Estate Services
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Low stock price volatilityVol 12M is 47% | Weak multi-year price returns2Y Excs Rtn is -24%, 3Y Excs Rtn is -64% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -2.7 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -50% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 352% | ||
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -1.2%, Rev Chg QQuarterly Revenue Change % is -1.8% | ||
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -44%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -44% | ||
| Key risksGYRO key risks include [1] a multi-year lack of revenue growth and stagnant earnings, Show more. |
| Low stock price volatilityVol 12M is 47% |
| Weak multi-year price returns2Y Excs Rtn is -24%, 3Y Excs Rtn is -64% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -2.7 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -50% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 352% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -1.2%, Rev Chg QQuarterly Revenue Change % is -1.8% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -44%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -44% |
| Key risksGYRO key risks include [1] a multi-year lack of revenue growth and stagnant earnings, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Gyrodyne (GYRO) stock has lost about 5% since 11/30/2025 because of the following key factors:
1. Amendment to a Key Asset Sale and Heightened Liquidation Risks.
On January 12, 2026, Gyrodyne amended its B2K sale agreement and notably flagged liquidation risks. This amendment followed a previously announced agreement on August 4, 2025, for the sale of a 49-acre parcel in Smithtown, New York, for an estimated $28.74 million, which had projected an increase in the estimated net asset value (NAV) per share to $14.83 as of June 30, 2025. The subsequent amendment and explicit mention of liquidation risks likely introduced investor uncertainty regarding the finalization and terms of this significant property sale, impacting the stock negatively.
2. Persistent Negative Technical Signals and Analyst Sentiment.
Throughout the period, Gyrodyne's stock has exhibited strong negative technical indicators. As of March 2, 2026, the stock held "sell signals from both short and long-term Moving Averages," with the long-term average being above the short-term average, indicating a negative forecast. Furthermore, a sell signal was issued from a pivot top point on February 2, 2026, after which the stock experienced a decline of 4.89%. Analysts have also maintained a "Strong Sell candidate" evaluation and an overall "Sell" technical rating for the stock as of late February 2026, based on a combination of technical signals, moving average trends, and other analyses.
Show more
1. Amendment to a Key Asset Sale and Heightened Liquidation Risks.
On January 12, 2026, Gyrodyne amended its B2K sale agreement and notably flagged liquidation risks. This amendment followed a previously announced agreement on August 4, 2025, for the sale of a 49-acre parcel in Smithtown, New York, for an estimated $28.74 million, which had projected an increase in the estimated net asset value (NAV) per share to $14.83 as of June 30, 2025. The subsequent amendment and explicit mention of liquidation risks likely introduced investor uncertainty regarding the finalization and terms of this significant property sale, impacting the stock negatively.
2. Persistent Negative Technical Signals and Analyst Sentiment.
Throughout the period, Gyrodyne's stock has exhibited strong negative technical indicators. As of March 2, 2026, the stock held "sell signals from both short and long-term Moving Averages," with the long-term average being above the short-term average, indicating a negative forecast. Furthermore, a sell signal was issued from a pivot top point on February 2, 2026, after which the stock experienced a decline of 4.89%. Analysts have also maintained a "Strong Sell candidate" evaluation and an overall "Sell" technical rating for the stock as of late February 2026, based on a combination of technical signals, moving average trends, and other analyses.
Show more
Stock Movement Drivers
Fundamental Drivers
The -6.4% change in GYRO stock from 11/30/2025 to 3/3/2026 was primarily driven by a -6.4% change in the company's P/E Multiple.| (LTM values as of) | 11302025 | 3032026 | Change |
|---|---|---|---|
| Stock Price ($) | 9.50 | 8.89 | -6.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 5 | 5 | 0.0% |
| Net Income Margin (%) | 0.9% | 0.9% | 0.0% |
| P/E Multiple | 26.4 | 24.7 | -6.4% |
| Shares Outstanding (Mil) | 0 | 0 | 0.0% |
| Cumulative Contribution | -6.4% |
Market Drivers
11/30/2025 to 3/3/2026| Return | Correlation | |
|---|---|---|
| GYRO | -6.4% | |
| Market (SPY) | -0.4% | 33.8% |
| Sector (XLRE) | 4.9% | 7.5% |
Fundamental Drivers
The -13.3% change in GYRO stock from 8/31/2025 to 3/3/2026 was primarily driven by a -13.3% change in the company's P/E Multiple.| (LTM values as of) | 8312025 | 3032026 | Change |
|---|---|---|---|
| Stock Price ($) | 10.25 | 8.89 | -13.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 5 | 5 | 0.0% |
| Net Income Margin (%) | 0.9% | 0.9% | 0.0% |
| P/E Multiple | 28.5 | 24.7 | -13.3% |
| Shares Outstanding (Mil) | 0 | 0 | 0.0% |
| Cumulative Contribution | -13.3% |
Market Drivers
8/31/2025 to 3/3/2026| Return | Correlation | |
|---|---|---|
| GYRO | -13.3% | |
| Market (SPY) | 5.8% | 5.7% |
| Sector (XLRE) | 4.1% | 6.0% |
Fundamental Drivers
The 1.5% change in GYRO stock from 2/28/2025 to 3/3/2026 was primarily driven by a 1.5% change in the company's P/E Multiple.| (LTM values as of) | 2282025 | 3032026 | Change |
|---|---|---|---|
| Stock Price ($) | 8.76 | 8.89 | 1.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 5 | 5 | 0.0% |
| Net Income Margin (%) | 0.9% | 0.9% | 0.0% |
| P/E Multiple | 24.3 | 24.7 | 1.5% |
| Shares Outstanding (Mil) | 0 | 0 | 0.0% |
| Cumulative Contribution | 1.5% |
Market Drivers
2/28/2025 to 3/3/2026| Return | Correlation | |
|---|---|---|
| GYRO | 1.5% | |
| Market (SPY) | 15.5% | 7.7% |
| Sector (XLRE) | 3.6% | 4.7% |
Fundamental Drivers
The 11.1% change in GYRO stock from 2/28/2023 to 3/3/2026 was primarily driven by a 11.1% change in the company's P/E Multiple.| (LTM values as of) | 2282023 | 3032026 | Change |
|---|---|---|---|
| Stock Price ($) | 8.00 | 8.89 | 11.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 5 | 5 | 0.0% |
| Net Income Margin (%) | 0.9% | 0.9% | 0.0% |
| P/E Multiple | 22.2 | 24.7 | 11.1% |
| Shares Outstanding (Mil) | 0 | 0 | 0.0% |
| Cumulative Contribution | 11.1% |
Market Drivers
2/28/2023 to 3/3/2026| Return | Correlation | |
|---|---|---|
| GYRO | 11.1% | |
| Market (SPY) | 78.1% | 5.1% |
| Sector (XLRE) | 25.5% | 8.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| GYRO Return | -29% | -30% | 23% | -10% | 2% | -4% | -45% |
| Peers Return | 18% | -11% | 25% | 22% | 31% | 12% | 132% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 1% | 83% |
Monthly Win Rates [3] | |||||||
| GYRO Win Rate | 42% | 33% | 58% | 33% | 33% | 33% | |
| Peers Win Rate | 57% | 43% | 58% | 67% | 63% | 80% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 67% | |
Max Drawdowns [4] | |||||||
| GYRO Max Drawdown | -35% | -30% | -4% | -23% | -17% | -6% | |
| Peers Max Drawdown | -12% | -24% | -9% | -12% | -6% | -2% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: WELL, VTR, OHI, SBRA, PLD.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/3/2026 (YTD)
How Low Can It Go
| Event | GYRO | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -54.4% | -25.4% |
| % Gain to Breakeven | 119.2% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -25.3% | -33.9% |
| % Gain to Breakeven | 33.8% | 51.3% |
| Time to Breakeven | Not Fully Recovered days | 148 days |
| 2018 Correction | ||
| % Loss | -25.3% | -19.8% |
| % Gain to Breakeven | 33.9% | 24.7% |
| Time to Breakeven | Not Fully Recovered days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -71.1% | -56.8% |
| % Gain to Breakeven | 245.7% | 131.3% |
| Time to Breakeven | 487 days | 1,480 days |
Compare to WELL, VTR, OHI, SBRA, PLD
In The Past
Gyrodyne's stock fell -54.4% during the 2022 Inflation Shock from a high on 4/9/2021. A -54.4% loss requires a 119.2% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Gyrodyne (GYRO)
Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.
AI Analysis | Feedback
A micro-cap Howard Hughes Corporation (HHC), focused on monetizing a small portfolio of legacy real estate assets.
AI Analysis | Feedback
- Real Estate Portfolio Management: Ownership and management of a significant land parcel located in St. James, New York.
- Land Development and Sales: Strategic planning for the development and eventual sale of their real estate holdings.
AI Analysis | Feedback
Gyrodyne (symbol: GYRO) has undergone significant changes in its business model. Historically, Gyrodyne operated as a real estate investment trust (REIT) that owned, managed, and leased commercial properties, primarily medical office and industrial spaces, located on Long Island, New York.
As such, its major customers were the *businesses* and *organizations* that leased space within its properties. The company sold primarily to other companies. Due to the nature of a REIT's operations, which typically involve numerous tenants rather than a few major ones, specific individual major customer names were not publicly disclosed. However, the categories of companies that were its tenants included:
- Healthcare Providers: Medical practices, clinics, laboratories, and other healthcare organizations leasing its medical office buildings.
- Industrial Businesses: Companies involved in manufacturing, distribution, warehousing, and other light industrial activities that leased space in its industrial parks.
It is important to note that Gyrodyne has largely completed the sale of its real estate assets in recent years (e.g., by the end of 2021). As a result, the company no longer has tenants as its primary customers and is in the process of winding down its operations and distributing capital to shareholders.
AI Analysis | Feedback
null
AI Analysis | Feedback
Gary J. Fitlin, Chief Executive Officer, President, Chief Financial Officer and Treasurer
Mr. Fitlin has served as Gyrodyne, LLC's Chief Executive Officer and President since May 1, 2017, and as Chief Financial Officer and Treasurer since joining the company in October 2009. From August 2012 to February 2013, he also served as interim President and Chief Executive Officer. Prior to joining Gyrodyne, he was the Director of Accounting Implementation for Lexington Realty Trust, a publicly traded real estate investment trust on the NYSE, from July 2006 to March 2008, where he was responsible for mergers and acquisitions. Before that, he held senior financial officer positions at various publicly traded companies, overseeing mergers and acquisitions, global accounting, management reporting, tax compliance and planning, financial systems, risk management, and contract administration. Mr. Fitlin is a Certified Public Accountant and an alumnus of Arthur Andersen & Co., holding a BS degree in Accounting and Economics from the State University of New York at Oswego.
Peter Pitsiokos, Executive Vice President, Chief Operating Officer, Chief Compliance Officer and Corporate Secretary
Mr. Pitsiokos has been with Gyrodyne, LLC since December 2003, initially serving as Chief Compliance Officer and Chief Operating Officer. His current roles include Executive Vice President, Chief Operating Officer, Chief Compliance Officer, and Corporate Secretary.
Dawn Ibraham, Controller
Ms. Ibraham has served as the Controller for Gyrodyne, LLC since joining the company in December 2012.
AI Analysis | Feedback
The key risks to Gyrodyne (GYRO) primarily stem from its business operations in the real estate sector and its financial performance:
- Lack of Revenue Growth and Stagnant Earnings: Gyrodyne has reported no revenue growth over the past year, and its earnings per share (EPS) remain stagnant. This indicates significant challenges in the company's profitability and overall operational efficiency. The company's business performance has been characterized by a lack of revenue growth over the past one, three, or five years, highlighting difficulties in expanding its operations and capitalizing on market opportunities.
- Real Estate Market Volatility and Economic Downturns: As a real estate company focused on owning and managing industrial and medical office buildings, Gyrodyne is inherently exposed to sector-specific risks such as market volatility and economic downturns. These external factors can significantly impact property values, occupancy rates, and rental income.
- Competitive Landscape within the Real Estate Industry: Gyrodyne faces potential difficulties in maintaining its competitive position, particularly against larger, more diversified real estate investment trusts (REITs). Its lack of consistent revenue growth and operational metrics may hinder its ability to compete effectively in the market.
AI Analysis | Feedback
nullAI Analysis | Feedback
Gyrodyne (NASDAQ: GYRO) operates as a real estate investment trust (REIT) primarily focusing on commercial properties within the New York metropolitan area, with a particular emphasis on medical office and industrial real estate.
The addressable markets for Gyrodyne's main products and services are as follows:
- Industrial Real Estate Market (New York Metropolitan Area, particularly Long Island): The New York City industrial market alone encompassed 158.9 million square feet of existing industrial space as of the second quarter of 2023. The Long Island industrial sector has shown significant activity, with 1.1 million square feet leased in the second quarter of 2023, nearly doubling the five-year quarterly average for the region. In early 2025, Long Island's industrial real estate was noted as the strongest performer, with rental rates surging and vacancy rates plummeting to 3.2% in key logistics hubs within Suffolk County. As of the third quarter of 2025, industrial vacancy on Long Island was 6.1%, with year-to-date Class A leasing totaling 344,979 square feet.
- Medical Office Real Estate Market (New York Metropolitan Area): Gyrodyne currently owns and manages approximately 50,000 square feet of medical office space in the suburbs of New York City. While specific overall market sizes for medical office space in the entire New York metropolitan area are not readily available, there is significant development activity. For instance, Gyrodyne's proposed Cortlandt Manor Medical Oriented District (MOD) plans for at least 80,000 square feet of Class A medical office space. Additionally, in Suffolk County, 45,000 square feet of lab space (a related but distinct category) is under construction near Stony Brook University.
- Age-Restricted Residential Community Development (Long Island, New York): null
AI Analysis | Feedback
Gyrodyne (symbol: GYRO) is a real estate company operating with a strategic focus on the liquidation and monetization of its property portfolio to maximize shareholder value. As such, the expected drivers of future revenue growth over the next 2-3 years are tied to the successful execution of this strategy rather than traditional recurring revenue streams.
- Strategic Property Sales: The primary driver of future revenue for Gyrodyne will be the successful sale of its real estate assets. The company's financial statements are prepared on a liquidation basis, reflecting its plan to sell properties and distribute the proceeds to shareholders. Recent developments include an agreement to sell a 49-acre parcel in Smithtown, New York, demonstrating active progress in this core strategy.
- Value Enhancement through Entitlements and Development Flexibility: Gyrodyne actively seeks to enhance the value of its properties by pursuing entitlements and favorable zoning changes. This includes efforts for its Flowerfield and Cortlandt Manor properties to increase development flexibility. Successfully securing these approvals significantly boosts the marketability and potential sale price of its land holdings.
- Effective Management of Litigation: Ongoing legal matters, such as the Article 78 proceeding related to the Flowerfield property, can impact the timeline and realized value from property sales. Favorable resolution or successful defense against such litigation is crucial for removing impediments to the liquidation process and protecting asset values, thereby indirectly driving revenue growth through unimpeded sales.
- Strategic Management and Capital Improvements of Real Estate Portfolio: While in liquidation, Gyrodyne's approach involves managing its diversified portfolio of office, industrial, and service-oriented properties in the New York metropolitan area. This includes investing in targeted capital improvements and securing long-term leases with creditworthy tenants to enhance asset value and maintain a resilient revenue base until properties are sold. These actions aim to maximize the sale price when properties are eventually divested.
- Leveraging Local Market Knowledge and Zoning Expertise: The company leverages its deep ties to the Long Island region, local market knowledge, and zoning expertise to support its development initiatives. This expertise is critical for successful entitlement efforts and repositioning its assets for optimal outcomes, directly contributing to higher realized values from property sales.
AI Analysis | Feedback
Share Issuance
- In March 2024, Gyrodyne completed an oversubscribed rights offering, which generated approximately $4.4 million in net proceeds. These funds were intended to support entitlement efforts, litigation costs, and general working capital.
- Gyrodyne announced in November 2023 that it anticipated receiving $1,979,165 in funding through the issuance of common shares.
Capital Expenditures
- Gyrodyne's strategy centers on enhancing the value of its properties in Flowerfield and Cortlandt Manor by pursuing entitlements to increase development flexibility, which involves associated costs.
- For the year ended December 31, 2023, the company incurred approximately $449,000 in land entitlement costs, primarily consisting of engineering costs, legal fees, and real estate taxes.
- As of August 2025, Gyrodyne estimates it may incur approximately $1.274 million in additional land entitlement costs through 2027 as part of its entitlement efforts.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| How Low Can Gyrodyne Stock Really Go? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to GYRO.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02272026 | KRC | Kilroy Realty | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02202026 | AAT | American Assets Trust | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | -0.2% | -0.2% | -1.5% |
| 12122025 | LINE | Lineage | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 11.7% | 11.7% | -7.3% |
| 11302025 | OHI | Omega Healthcare Investors | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 6.7% | 6.7% | -6.0% |
| 10312025 | ADC | Agree Realty | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 11.8% | 11.8% | -2.8% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 66.98 |
| Mkt Cap | 27.4 |
| Rev LTM | 3,512 |
| Op Inc LTM | 550 |
| FCF LTM | 940 |
| FCF 3Y Avg | 742 |
| CFO LTM | 1,263 |
| CFO 3Y Avg | 1,057 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 11.7% |
| Rev Chg 3Y Avg | 11.5% |
| Rev Chg Q | 15.2% |
| QoQ Delta Rev Chg LTM | 3.7% |
| Op Mgn LTM | 24.4% |
| Op Mgn 3Y Avg | 23.8% |
| QoQ Delta Op Mgn LTM | -0.5% |
| CFO/Rev LTM | 36.6% |
| CFO/Rev 3Y Avg | 53.2% |
| FCF/Rev LTM | 35.9% |
| FCF/Rev 3Y Avg | 53.2% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 27.4 |
| P/S | 9.4 |
| P/EBIT | 23.3 |
| P/E | 36.1 |
| P/CFO | 20.4 |
| Total Yield | 3.4% |
| Dividend Yield | 1.1% |
| FCF Yield 3Y Avg | 5.9% |
| D/E | 0.3 |
| Net D/E | 0.3 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 10.2% |
| 3M Rtn | 5.7% |
| 6M Rtn | 19.8% |
| 12M Rtn | 28.0% |
| 3Y Rtn | 105.8% |
| 1M Excs Rtn | 12.0% |
| 3M Excs Rtn | 6.0% |
| 6M Excs Rtn | 14.2% |
| 12M Excs Rtn | 15.4% |
| 3Y Excs Rtn | 30.2% |
Price Behavior
Price Behavior
| Market Price | $8.89 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 08/18/1995 | |
| Distance from 52W High | -17.2% | |
| 50 Days | 200 Days | |
| DMA Price | $9.51 | $8.83 |
| DMA Trend | indeterminate | down |
| Distance from DMA | -6.5% | 0.6% |
| 3M | 1YR | |
| Volatility | 38.8% | 67.7% |
| Downside Capture | 77.37 | 51.60 |
| Upside Capture | 9.82 | 45.31 |
| Correlation (SPY) | 23.4% | 4.8% |
GYRO Betas & Captures as of 2/28/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.13 | 0.48 | 0.52 | 0.11 | 0.11 | 0.09 |
| Up Beta | -0.07 | 0.90 | 0.93 | 0.77 | 0.07 | 0.03 |
| Down Beta | 0.14 | 0.91 | 1.06 | 0.88 | 0.23 | 0.12 |
| Up Capture | -16% | -2% | -6% | -45% | 5% | 3% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 4 | 6 | 8 | 27 | 54 | 158 |
| Down Capture | -32% | 32% | 38% | -33% | 11% | 24% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 3 | 6 | 10 | 33 | 57 | 181 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GYRO | |
|---|---|---|---|---|
| GYRO | 20.8% | 53.1% | 1.48 | - |
| Sector ETF (XLRE) | 3.6% | 16.5% | 0.04 | 10.7% |
| Equity (SPY) | 15.6% | 19.3% | 0.63 | 15.6% |
| Gold (GLD) | 79.3% | 26.1% | 2.22 | 2.4% |
| Commodities (DBC) | 17.8% | 17.1% | 0.80 | 8.8% |
| Real Estate (VNQ) | 5.6% | 16.6% | 0.16 | 15.1% |
| Bitcoin (BTCUSD) | -18.7% | 45.2% | -0.32 | -7.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GYRO | |
|---|---|---|---|---|
| GYRO | 2.1% | 53.6% | 0.30 | - |
| Sector ETF (XLRE) | 5.8% | 19.1% | 0.21 | 9.3% |
| Equity (SPY) | 13.2% | 17.0% | 0.61 | 12.7% |
| Gold (GLD) | 22.8% | 17.3% | 1.08 | 8.6% |
| Commodities (DBC) | 10.8% | 19.0% | 0.46 | 4.8% |
| Real Estate (VNQ) | 4.8% | 18.8% | 0.16 | 11.0% |
| Bitcoin (BTCUSD) | 6.7% | 56.8% | 0.34 | 1.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GYRO | |
|---|---|---|---|---|
| GYRO | 0.3% | 34.6% | 0.12 | - |
| Sector ETF (XLRE) | 7.7% | 20.4% | 0.34 | 1.3% |
| Equity (SPY) | 15.3% | 17.9% | 0.74 | 0.7% |
| Gold (GLD) | 14.9% | 15.6% | 0.80 | 0.6% |
| Commodities (DBC) | 9.1% | 17.6% | 0.43 | 2.2% |
| Real Estate (VNQ) | 6.5% | 20.7% | 0.28 | 1.8% |
| Bitcoin (BTCUSD) | 66.5% | 66.8% | 1.06 | 0.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2015 | 08/14/2015 | 10-Q |
| 03/31/2015 | 05/15/2015 | 10-Q |
| 12/31/2014 | 03/31/2015 | 10-K |
| 09/30/2014 | 11/05/2014 | 10-Q |
| 06/30/2014 | 08/08/2014 | 10-Q |
| 03/31/2014 | 05/12/2014 | 10-Q |
| 12/31/2013 | 03/25/2014 | 10-K |
| 09/30/2013 | 11/12/2013 | 10-Q |
| 06/30/2013 | 08/09/2013 | 10-Q |
| 03/31/2013 | 05/10/2013 | 10-Q |
| 12/31/2012 | 03/18/2013 | 10-K |
| 09/30/2012 | 11/14/2012 | 10-Q |
| 06/30/2012 | 08/13/2012 | 10-Q |
| 09/30/2011 | 11/09/2011 | 10-Q |
| 06/30/2011 | 08/12/2011 | 10-Q |
| 03/31/2011 | 05/12/2011 | 10-Q |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.